Photocure ASA
OSE:PHO
Photocure ASA
Income from Continuing Operations
Photocure ASA
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Photocure ASA
OSE:PHO
|
Income from Continuing Operations
-kr4.8m
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
|
V
|
Vistin Pharma ASA
OSE:VISTN
|
Income from Continuing Operations
kr62.7m
|
CAGR 3-Years
36%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
N
|
Navamedic ASA
OSE:NAVA
|
Income from Continuing Operations
kr1.3m
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
SoftOx Solutions AS
OSE:SOFTX
|
Income from Continuing Operations
-kr86.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Photocure ASA
Glance View
Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.
See Also
What is Photocure ASA's Income from Continuing Operations?
Income from Continuing Operations
-4.8m
NOK
Based on the financial report for Dec 31, 2024, Photocure ASA's Income from Continuing Operations amounts to -4.8m NOK.
What is Photocure ASA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
15%
The average annual Income from Continuing Operations growth rates for Photocure ASA have been 46% over the past three years , and 15% over the past ten years .
You don't have any saved screeners yet